These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 20174749

  • 1. Anti-platelet therapy: is it all over in peripheral artery disease?
    Jaipersad AS, Silverman SH, Lip GY.
    Thromb Haemost; 2010 Apr; 103(4):689-91. PubMed ID: 20174749
    [No Abstract] [Full Text] [Related]

  • 2. Comparison of efficacy of antiplatelet treatments for patients with claudication. A meta-analysis.
    Basili S, Raparelli V, Vestri A, Di Tanna GL, Violi F.
    Thromb Haemost; 2010 Apr; 103(4):766-73. PubMed ID: 20174763
    [Abstract] [Full Text] [Related]

  • 3. Intermittent claudication: a plea for guidelines for medical management.
    Powell JT.
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
    [No Abstract] [Full Text] [Related]

  • 4. Three-year cardiovascular events and disease progress in patients with peripheral arterial disease: results from the Japan Medication Therapy for Peripheral Arterial Disease (J-METHOD).
    Shigematsu H, Nishibe T, Obitsu Y, Matsuzaki K, Ishida A, Miyata T, Shindo S, Hida K, Ohta T, Ando M, Kawasaki T, Yasugi T, Matsumoto T.
    Int Angiol; 2010 Apr; 29(2 Suppl):2-13. PubMed ID: 20357743
    [Abstract] [Full Text] [Related]

  • 5. Optimal medical management of peripheral arterial disease.
    Rice TW, Lumsden AB.
    Vasc Endovascular Surg; 2006 Apr; 40(4):312-27. PubMed ID: 16959725
    [Abstract] [Full Text] [Related]

  • 6. Control of hypertension in patients with peripheral artery disease.
    Clement DL.
    Blood Press; 2006 Apr; 15(4):251-2. PubMed ID: 17078187
    [No Abstract] [Full Text] [Related]

  • 7. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 8. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O, Welten GM, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2008 Jan 12; 35(1):59-60. PubMed ID: 17719805
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agents, and statins.
    Dagher NN, Modrall JG.
    Semin Vasc Surg; 2007 Mar 12; 20(1):10-4. PubMed ID: 17386359
    [Abstract] [Full Text] [Related]

  • 10. Antiplatelet therapy to prevent cardiovascular events and mortality in patients with intermittent claudication.
    Wong PF, Chong LY, Stansby G.
    JAMA; 2013 Mar 06; 309(9):926-7. PubMed ID: 23462789
    [Abstract] [Full Text] [Related]

  • 11. Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry.
    Khan S, Flather M, Mister R, Delahunty N, Fowkes G, Bradbury A, Stansby G.
    Eur J Vasc Endovasc Surg; 2007 Apr 06; 33(4):442-50. PubMed ID: 17196851
    [Abstract] [Full Text] [Related]

  • 12. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI.
    J Vasc Surg; 2008 Sep 06; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract] [Full Text] [Related]

  • 13. Peripheral arterial occlusive disease: conservative treatment of intermittent claudication.
    Kriessmann A.
    J Cardiovasc Pharmacol; 1990 Sep 06; 16 Suppl 3():S72-4. PubMed ID: 1369724
    [Abstract] [Full Text] [Related]

  • 14. Antithrombotic therapy in peripheral arterial disease.
    Lipsitz EC, Kim S.
    Clin Geriatr Med; 2006 Feb 06; 22(1):183-98, x. PubMed ID: 16377474
    [Abstract] [Full Text] [Related]

  • 15. Prevalence of (a)symptomatic peripheral arterial disease; the additional value of ankle-brachial index on cardiovascular risk stratification.
    van Kuijk JP, Flu WJ, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2009 Sep 06; 38(3):312-3. PubMed ID: 19524459
    [No Abstract] [Full Text] [Related]

  • 16. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management.
    Ferreira AC, Macedo FY.
    Ann Med; 2010 Mar 06; 42(2):139-50. PubMed ID: 20156042
    [Abstract] [Full Text] [Related]

  • 17. Update on peripheral arterial disease and claudication rehabilitation.
    Salameh MJ, Ratchford EV.
    Phys Med Rehabil Clin N Am; 2009 Nov 06; 20(4):627-56. PubMed ID: 19781503
    [Abstract] [Full Text] [Related]

  • 18. Consensus on anti-platelet therapy in peripheral arterial disease: saving lives and limbs.
    Donnelly R, Collinson DJ.
    Platelets; 2003 Nov 06; 14(7-8):403-6. PubMed ID: 14713508
    [No Abstract] [Full Text] [Related]

  • 19. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb 06; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 20. [The future prospects of antithrombotic therapy in peripheral vasculopathy].
    Violi F, Loffredo L, Annessi M.
    Ann Ital Med Int; 1999 Feb 06; 14(3):185-91. PubMed ID: 10566184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.